• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

    10/4/23 8:03:28 AM ET
    $AGIL
    $ATEN
    $BCLI
    $BROG
    Professional Services
    Consumer Discretionary
    Computer Communications Equipment
    Telecommunications
    Get the next $AGIL alert in real time by email

    Gainers

    • Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares rose 72.4% to $0.2930 in pre-market trading after falling 15% on Tuesday. Brainstorm Cell Therapeutics recently announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS.
    • Sonendo, Inc. (NYSE:SONX) shares gained 38% to $0.4416 in pre-market trading after dipping over 55% on Tuesday. Sonendo recently revealed receipt of notice of non-compliance with NYSE trading share price listing rule.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) shares rose 29.8% to $0.5205 in pre-market trading after falling around 7% on Tuesday. Senti Biosciences recently received a notice of allowance for its U.S. patent application 17/338,528 titled "Chimeric Receptors and Methods of Use Thereof (for Treatment of Acute Myeloid Leukemia)."
    • Brooge Energy Limited (NASDAQ:BROG) shares rose 23.5% to $6.78 in pre-market trading after the company announced GULFNAV submitted a proposal to acquire all of its businesses and assets.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) rose 11.6% to $0.1799 in pre-market trading after gaining around 11% on Tuesday.
    • Trio Petroleum Corp. (NYSE:TPET) rose 11.2% to $0.6660 in pre-market trading after gaining 7% on Tuesday.
    • FLJ Group Limited (NASDAQ:FLJ) shares surged 10.8% to $0.2480 in pre-market trading. FLJ Group recently entered into a definitive agreement to acquire Lianlian Holdings Inc.
    • Globus Maritime Limited (NASDAQ:GLBS) shares climbed 10.3% to $2.14 in pre-market trading. Globus Maritime regained compliance with NASDAQ's minimum closing bid price.
    • FingerMotion, Inc. (NASDAQ:FNGR) gained 10.3% to $5.05 in pre-market trading after falling 35% on Tuesday. Capybara Research recently issued a short report on the company titled "FingerMotion: A Serial Case of Stock Promotion That Will End In Shareholder Dilution. $1 Target."
    • CalAmp Corp. (NASDAQ:CAMP) shares jumped 7.1% to $0.44 in pre-market trading. CalAmp is expected to release its fiscal 2024 second quarter financial results on Oct. 5, 2023.

    Losers

    • Lithium Americas Corp. (NYSE:LAC) fell 28% to $11.65 in pre-market trading. Lithium Americas reported the completion of the reorganization of Lithium Americas into two independent publicly traded companies.
    • Molekule Group, Inc. (NASDAQ:MKUL) shares fell 25.6% to $0.1526 in pre-market trading. Molekule Group and its subsidiary have filed for Chapter 11 bankruptcy and will operate as a debtor in possession, seeking a credit facility of $5 million from dip lenders including Foundry Group Next, Armistice Capital Master Fund, SVBC, Bridge Coast Capital.
    • MSP Recovery, Inc. (NASDAQ:LIFW) fell 22.6% to $0.1935 in pre-market trading after the company announced a 1-for-25 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.
    • Femasys Inc. (NASDAQ:FEMY) fell 20.1% to $1.99 in pre-market trading after dipping 36% on Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 16.5% to $1.42 in pre-market trading after declining more than 12% on Tuesday.
    • AgileThought, Inc. (NASDAQ:AGIL) shares fell 15.2% to $0.1442 in pre-market trading after gaining over 6% on Tuesday.
    • VIQ Solutions Inc. (NASDAQ:VQS) fell 14.7% to $0.1420 in pre-market trading after gaining 27% on Tuesday. Last Wednesday, VIQ Solutions announced the delisting of its stock from the Nasdaq and the resignation of its director.
    • GSE Systems, Inc. (NASDAQ:GVP) fell 12.7% to $0.1807 in pre-market trading.
    • Cal-Maine Foods, Inc. (NASDAQ:CALM) fell 12.4% to $41.60 in pre-market after the company posted weaker-than-expected sales for its first quarter on Tuesday.
    • A10 Networks, Inc. (NYSE:ATEN) shares fell 11.7% to $13.39 in pre-market trading after the company reported preliminary results for the third quarter. The company expects revenue to be $56.5 million to $58.5 million.

     

    Now Read This: RPM International, Acuity Brands And 3 Stocks To Watch Heading Into Wednesday

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $ATEN
    $BCLI
    $BROG

    CompanyDatePrice TargetRatingAnalyst
    Cal-Maine Foods Inc.
    $CALM
    12/1/2025$100.00Buy
    The Benchmark Company
    Femasys Inc.
    $FEMY
    11/20/2025$6.50Buy
    Laidlaw
    Lithium Americas Corp.
    $LAC
    11/19/2025Sell → Hold
    Canaccord Genuity
    Lithium Americas Corp.
    $LAC
    11/6/2025$5.00Underweight → Neutral
    Analyst
    Lithium Americas Corp.
    $LAC
    10/16/2025$5.00Neutral → Underweight
    Analyst
    Senti Biosciences Inc.
    $SNTI
    10/14/2025$12.00Buy
    H.C. Wainwright
    Lithium Americas Corp.
    $LAC
    10/6/2025$5.00Sector Perform → Sector Underperform
    Scotiabank
    CAMP4 Therapeutics Corporation
    $CAMP
    10/2/2025$7.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Cal-Maine Foods with a new price target

    The Benchmark Company initiated coverage of Cal-Maine Foods with a rating of Buy and set a new price target of $100.00

    12/1/25 8:27:17 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Laidlaw initiated coverage on Femasys with a new price target

    Laidlaw initiated coverage of Femasys with a rating of Buy and set a new price target of $6.50

    11/20/25 8:06:38 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Lithium Americas upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Lithium Americas from Sell to Hold

    11/19/25 8:47:22 AM ET
    $LAC
    Metal Mining
    Basic Materials

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tardiff Daniel

    4 - Camp4 Therapeutics Corp (0001736730) (Issuer)

    4/3/26 4:48:21 PM ET
    $CAMP

    SEC Form 4 filed by Maricich Yuri

    4 - Camp4 Therapeutics Corp (0001736730) (Issuer)

    4/3/26 4:47:38 PM ET
    $CAMP

    SEC Form 4 filed by Gold Kelly

    4 - Camp4 Therapeutics Corp (0001736730) (Issuer)

    4/3/26 4:47:04 PM ET
    $CAMP

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

    ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating Officer. Mr. Canning is an accomplished medical device executive with more than 25 years of experience leading global operations and technology organizations within complex medical device companies. He brings a track record of scaling organizations, advancing product pipelines, and driving operational excellence across key functions to support commercial growth and product adoption. Prior to joining

    4/1/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies

    SOUTH SAN FRANCISCO, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced the publication of new peer-reviewed research in Cell Systems demonstrating its systematic framework for engineering NOT-gated chimeric antigen receptor (CAR) circuits in both T cells and natural killer (NK) cells. The study demonstrates how Logic-Gated receptor designs can significantly improve the efficacy, precision, and safety of cell therapies by enabling immune cells to selectively eliminate tumor cells while sparing hea

    4/1/26 8:45:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cal-Maine Foods Reports Third Quarter Fiscal 2026 Results

    RIDGELAND, Miss., April 01, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM) ("Cal-Maine Foods," "we," "us," "our" or the "company"), the largest egg company in the United States and a leading player in the egg-based food industry, today reported results for its fiscal 2026 third quarter, ended February 28, 2026. Unless otherwise indicated, all comparisons are to the comparable period of fiscal 2025. Strategic Execution Highlights Continued focus on sales diversification and mix shift, expected to strengthen earnings durability and predictability over timeIn the third quarter of fiscal 2026: Specialty eggs sales increased to 50.5% of total shell egg sales, up 2,610 basis poin

    4/1/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $AGIL
    $ATEN
    $BCLI
    $BROG
    SEC Filings

    View All

    SEC Form DEFA14A filed by Trio Petroleum Corp.

    DEFA14A - Trio Petroleum Corp (0001898766) (Filer)

    4/6/26 4:10:31 PM ET
    $TPET
    Oil & Gas Production
    Energy

    SEC Form DEF 14A filed by Trio Petroleum Corp.

    DEF 14A - Trio Petroleum Corp (0001898766) (Filer)

    4/6/26 4:05:31 PM ET
    $TPET
    Oil & Gas Production
    Energy

    SEC Form DEF 14A filed by Femasys Inc.

    DEF 14A - FEMASYS INC (0001339005) (Filer)

    4/6/26 4:01:10 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 5% to 190,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    10/29/25 4:01:44 PM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Financials

    Live finance-specific insights

    View All

    Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies

    SOUTH SAN FRANCISCO, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced the publication of new peer-reviewed research in Cell Systems demonstrating its systematic framework for engineering NOT-gated chimeric antigen receptor (CAR) circuits in both T cells and natural killer (NK) cells. The study demonstrates how Logic-Gated receptor designs can significantly improve the efficacy, precision, and safety of cell therapies by enabling immune cells to selectively eliminate tumor cells while sparing hea

    4/1/26 8:45:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cal-Maine Foods Reports Third Quarter Fiscal 2026 Results

    RIDGELAND, Miss., April 01, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM) ("Cal-Maine Foods," "we," "us," "our" or the "company"), the largest egg company in the United States and a leading player in the egg-based food industry, today reported results for its fiscal 2026 third quarter, ended February 28, 2026. Unless otherwise indicated, all comparisons are to the comparable period of fiscal 2025. Strategic Execution Highlights Continued focus on sales diversification and mix shift, expected to strengthen earnings durability and predictability over timeIn the third quarter of fiscal 2026: Specialty eggs sales increased to 50.5% of total shell egg sales, up 2,610 basis poin

    4/1/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

    ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to date Initiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval.Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight.FemBloc permanent birth control system achieved certification under the Medical Device Single Au

    3/31/26 4:05:00 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Leadership Updates

    Live Leadership Updates

    View All

    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

    ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating Officer. Mr. Canning is an accomplished medical device executive with more than 25 years of experience leading global operations and technology organizations within complex medical device companies. He brings a track record of scaling organizations, advancing product pipelines, and driving operational excellence across key functions to support commercial growth and product adoption. Prior to joining

    4/1/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Cal-Maine Foods Welcomes Dudley D. Wooley to Board of Directors

    RIDGELAND, Miss., April 01, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced the appointment of Dudley D. Wooley to its Board of Directors. Mr. Wooley brings extensive leadership experience in risk management, business strategy, and governance, further strengthening the Board's depth of expertise as the Company continues executing its long-term growth strategy. Mr. Wooley currently serves as Chief Executive Officer of Ross & Yerger Insurance, Inc., a super-regional, employee-owned independent insurance agency headquartered in Jackson, Mississippi. With more than t

    4/1/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    CAMP4 Appoints Michael MacLean to its Board of Directors

    CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (NASDAQ:CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the appointment of Michael MacLean to the Company's Board of Directors. "Mike brings an exceptional depth of financial and operational expertise built across decades of leadership at some of the most innovative biotechnology companies, and we are thrilled to welcome him to CAMP4's Board," said Josh Mandel-Brehm, Pr

    3/24/26 7:00:00 AM ET
    $CAMP

    $AGIL
    $ATEN
    $BCLI
    $BROG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by GSE Systems Inc.

    SC 13G/A - GSE SYSTEMS INC (0000944480) (Subject)

    11/14/24 7:13:40 PM ET
    $GVP
    Computer Software: Prepackaged Software
    Technology